FDA Approved: CREON — Supplemental Application (AbbVie Inc.)

View source ↗

Summary

The FDA issued a supplemental approval for CREON (pancrelipase) from AbbVie, expanding its indication for exocrine pancreatic insufficiency.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Exocrine Pancreatic Insufficiency

Drugs mentioned

• Creon (pancrelipase)

Snippet

SUPPL AP for CREON (PANCRELIPASE)